2020
DOI: 10.1089/met.2019.0074
|View full text |Cite
|
Sign up to set email alerts
|

Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 43 publications
0
6
0
Order By: Relevance
“…The results led the authors to suggest that the circulating monocytes of OA patients are activated prior to their entry into the synovium. Also, studies focussing on MetS patients and patients with familial hypercholesterolemia have shown that their circulating monocytes show a pro-inflammatory phenotype and increased migratory capacity, as shown by increased expression of chemokine receptors, monocyte chemotactic protein-1 (MCP-1) and activation markers compared with healthy individuals [ 59–61 ]. Interestingly, several studies have shown that this was downregulated after treatment with the LDL-lowering drugs atorvastatin and PCSK9 inhibitors [ 60–62 ], suggesting that LDL is a MetS-associated factor that mediates activation of circulating monocytes.…”
Section: Can Metabolic Activation Of Circulating Monocytes Drive a Sy...mentioning
confidence: 99%
“…The results led the authors to suggest that the circulating monocytes of OA patients are activated prior to their entry into the synovium. Also, studies focussing on MetS patients and patients with familial hypercholesterolemia have shown that their circulating monocytes show a pro-inflammatory phenotype and increased migratory capacity, as shown by increased expression of chemokine receptors, monocyte chemotactic protein-1 (MCP-1) and activation markers compared with healthy individuals [ 59–61 ]. Interestingly, several studies have shown that this was downregulated after treatment with the LDL-lowering drugs atorvastatin and PCSK9 inhibitors [ 60–62 ], suggesting that LDL is a MetS-associated factor that mediates activation of circulating monocytes.…”
Section: Can Metabolic Activation Of Circulating Monocytes Drive a Sy...mentioning
confidence: 99%
“…Pro-inflammatory markers, such as tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), and leptin, demonstrate a positive correlation with insulin resistance and the characteristics of MetS [23]. Moreover, deregulation of the production of monocyte chemoattractant protein-1 (MCP-1) was observed in MetS patients as a consequence of oxidative stress [24]. An increase in systemic pro-inflammatory and oxidative stress conditions has been observed in MetS patients of both genders when compared to those without MetS [25].…”
Section: Introductionmentioning
confidence: 99%
“…This innate immaturity is characterized by altered cytokines production and decreased function of antigen-presenting cells 9 , 10 . Blood culture remains the gold standard for the diagnosis of neonatal sepsis, but beside delayed results and low sensitivity, cost and access to those techniques in RLS limit its use 11 , 12 . Other tests routinely used for the diagnosis of neonatal sepsis, such as C-reactive protein (CRP) and blood count (total and differential white blood cell counts, absolute and immature neutrophil counts, and the ratio of immature to total neutrophils), are not unanimously recognized as good biomarkers of neonatal sepsis, respectively having a low specificity and lack of sensitiveness 13 – 16 .…”
Section: Introductionmentioning
confidence: 99%